Skip to main content

Wealthfront Advisers LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1763921 Palo Alto, CA

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$20,667,941
-$49,282 QoQ
Shares Held
41,608
-10.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#256
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Wealthfront Advisers LLC holds $35,327,037 across 19 Biotechnology names. VRTX ranks #1 (58.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
41,608 $20,667,941

All Filings in VRTX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,667,941 41,608
2026-03-31 $20,717,223 46,395
2025-12-31 $19,571,097 43,169
2025-09-30 $14,636,761 37,373
2025-06-30 $19,552,293 43,918
2025-03-31 $22,753,572 46,932
2024-12-31 $16,518,351 41,019
2024-09-30 $18,231,136 39,200
2024-06-30 $18,603,496 39,690
2024-03-31 $16,886,349 40,397
2023-12-31 $16,544,147 40,660
2023-09-30 $14,349,491 41,265
2023-06-30 $14,646,846 41,621
2023-03-31 $12,564,676 39,879
2022-12-31 $10,106,144 34,996
2022-09-30 $11,153,370 38,521
2022-06-30 $9,559,725 33,925
2022-03-31 $4,008,238 15,359
2021-12-31 $1,564,210 7,123
2021-09-30 $1,033,560 5,698
2021-06-30 $1,143,645 5,672
2021-03-31 $2,050,265 9,541
2020-12-31 $1,957,131 8,281
2020-09-30 $2,506,497 9,211
2020-06-30 $2,675,496 9,216
2020-03-31 $1,971,653 8,286